Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birol Emir

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
Journal of Pain Research|October 28, 2016
Improvement in pain severity category in clinical trials of pregabalinBruce Parsons, Charles E Argoff, Andrew Clair, et al.
Expert Opinion on Pharmacotherapy|September 4, 2010
Treatment response to pregabalin in fibromyalgia pain: effect of patient baseline characteristicsBirol Emir, Thomas Kevin Murphy, Danielle Lauren Petersel, et al.
Current Medical Research and Opinion|September 4, 2013
Efficacy and safety of pregabalin in patients with spinal cord injury: a pooled analysisBruce Parsons, Luis Sanin, Ruoyong Yang, et al.
Pain|January 30, 2014
Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signsRoy Freeman, Ralf Baron, Didier Bouhassira, et al.
Current Medical Research and Opinion|May 13, 2011
Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trialsBasim M Uthman, Mary Almas, Birol Emir, et al.
Epilepsy Research|June 4, 2013
Designing a new proof-of-principle trial for treatment of partial seizures to demonstrate efficacy with minimal sample size and duration-a case studyJacqueline A French, Javier Cabrera, Birol Emir, et al.
BMC Family Practice|November 9, 2010
Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studiesDavid Semel, T Kevin Murphy, Gergana Zlateva, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 29, 2021
Finite Mixture Models, a Flexible Alternative to Standard Modeling Techniques for Extrapolated Mean Survival Times Needed for Cost-Effectiveness AnalysesPaul R Cislo, Birol Emir, Javier Cabrera, et al.
Pain Medicine (Malden, Mass.)|January 27, 2011
Correlations between fibromyalgia symptom and function domains and patient global impression of change: a pooled analysis of three randomized, placebo-controlled trials of pregabalinLesley M Arnold, Gergana Zlateva, Alesia Sadosky, et al.
Pain Medicine (Malden, Mass.)|December 23, 2014
Time to improvement of pain and sleep quality in clinical trials of pregabalin for the treatment of fibromyalgiaLesley M Arnold, Birol Emir, Lynne Pauer, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
Journal of Pain Research|October 28, 2016
Improvement in pain severity category in clinical trials of pregabalinBruce Parsons, Charles E Argoff, Andrew Clair, et al.
Expert Opinion on Pharmacotherapy|September 4, 2010
Treatment response to pregabalin in fibromyalgia pain: effect of patient baseline characteristicsBirol Emir, Thomas Kevin Murphy, Danielle Lauren Petersel, et al.
Current Medical Research and Opinion|September 4, 2013
Efficacy and safety of pregabalin in patients with spinal cord injury: a pooled analysisBruce Parsons, Luis Sanin, Ruoyong Yang, et al.
Pain|January 30, 2014
Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signsRoy Freeman, Ralf Baron, Didier Bouhassira, et al.
Current Medical Research and Opinion|May 13, 2011
Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trialsBasim M Uthman, Mary Almas, Birol Emir, et al.
Epilepsy Research|June 4, 2013
Designing a new proof-of-principle trial for treatment of partial seizures to demonstrate efficacy with minimal sample size and duration-a case studyJacqueline A French, Javier Cabrera, Birol Emir, et al.
BMC Family Practice|November 9, 2010
Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studiesDavid Semel, T Kevin Murphy, Gergana Zlateva, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 29, 2021
Finite Mixture Models, a Flexible Alternative to Standard Modeling Techniques for Extrapolated Mean Survival Times Needed for Cost-Effectiveness AnalysesPaul R Cislo, Birol Emir, Javier Cabrera, et al.
Pain Medicine (Malden, Mass.)|January 27, 2011
Correlations between fibromyalgia symptom and function domains and patient global impression of change: a pooled analysis of three randomized, placebo-controlled trials of pregabalinLesley M Arnold, Gergana Zlateva, Alesia Sadosky, et al.
Pain Medicine (Malden, Mass.)|December 23, 2014
Time to improvement of pain and sleep quality in clinical trials of pregabalin for the treatment of fibromyalgiaLesley M Arnold, Birol Emir, Lynne Pauer, et al.
Pageof 11